SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Johnson & Johnson Says Tremfya Psoriatic Arthritis Trial Meets Endpoints

Johnson & Johnson said a Phase 4 trial of Tremfya in psoriatic arthritis met its endpoints.

JNJ

Related stories